PT855916E - Composicao farmaceutica contendo um estimulador de activina ou inibina - Google Patents

Composicao farmaceutica contendo um estimulador de activina ou inibina

Info

Publication number
PT855916E
PT855916E PT96935035T PT96935035T PT855916E PT 855916 E PT855916 E PT 855916E PT 96935035 T PT96935035 T PT 96935035T PT 96935035 T PT96935035 T PT 96935035T PT 855916 E PT855916 E PT 855916E
Authority
PT
Portugal
Prior art keywords
activine
stimulator
inhibit
pharmaceutical composition
composition containing
Prior art date
Application number
PT96935035T
Other languages
English (en)
Inventor
Mark William James Ferguson
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of PT855916E publication Critical patent/PT855916E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
PT96935035T 1995-10-21 1996-10-17 Composicao farmaceutica contendo um estimulador de activina ou inibina PT855916E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9521608A GB2306481A (en) 1995-10-21 1995-10-21 Pharmaceutical comprising a stimulator of activin and/or inhibin

Publications (1)

Publication Number Publication Date
PT855916E true PT855916E (pt) 2004-11-30

Family

ID=10782702

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96935035T PT855916E (pt) 1995-10-21 1996-10-17 Composicao farmaceutica contendo um estimulador de activina ou inibina

Country Status (13)

Country Link
US (1) US7713933B2 (pt)
EP (1) EP0855916B1 (pt)
JP (1) JP4102437B2 (pt)
AT (1) ATE275966T1 (pt)
AU (1) AU715255B2 (pt)
CA (1) CA2235412C (pt)
DE (1) DE69633396T2 (pt)
DK (1) DK0855916T3 (pt)
ES (1) ES2227610T3 (pt)
GB (1) GB2306481A (pt)
PT (1) PT855916E (pt)
WO (1) WO1997015321A1 (pt)
ZA (1) ZA968785B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6004937A (en) * 1998-03-09 1999-12-21 Genetics Institute, Inc. Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11]
NZ519546A (en) * 1999-12-15 2005-07-29 Res Dev Foundation Betaglycan as an inhibin receptor and uses thereof
JP4487376B2 (ja) 2000-03-31 2010-06-23 味の素株式会社 腎疾患治療剤
US8128933B2 (en) 2005-11-23 2012-03-06 Acceleron Pharma, Inc. Method of promoting bone growth by an anti-activin B antibody
TW202021980A (zh) 2007-02-02 2020-06-16 美商艾瑟勒朗法瑪公司 衍生自ActRIIB的變體與其用途
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
EP3363453A1 (en) 2008-06-26 2018-08-22 Acceleron Pharma Inc. Soluble actriia as activin-actriia antagonist for use in treating anemia or bone-related disorders
US8216997B2 (en) 2008-08-14 2012-07-10 Acceleron Pharma, Inc. Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
CN113583104A (zh) 2014-06-04 2021-11-02 阿塞勒隆制药公司 促滤泡素抑制素多肽、其组合物及其使用方法
US10010498B2 (en) 2014-06-04 2018-07-03 Acceleron Pharma Inc. Methods for treatment of amyotrophic lateral sclerosis with follistatin fusion proteins
US9975934B2 (en) 2015-03-26 2018-05-22 Acceleron Pharma Inc. Follistatin-related fusion proteins
US11230583B2 (en) 2015-11-26 2022-01-25 Hudson Institute of Medical Research Inhibin analogs
CN115404199B (zh) * 2022-11-01 2023-03-21 广州优特佳生物科技发展有限公司 活化素b在促进透明质酸合成中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0368992B1 (en) * 1988-05-31 1995-02-15 Biotechnology Australia Pty. Ltd. Actions of hormones
US5071834A (en) * 1988-09-16 1991-12-10 Genentech, Inc. Purified activin B composition
US4997815A (en) * 1988-11-01 1991-03-05 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
JPH0651638B2 (ja) * 1989-02-13 1994-07-06 新技術事業団 角膜上皮創傷治療用点眼剤
US5102868A (en) * 1990-01-08 1992-04-07 Genentech, Inc. Method for inhibiting follicular maturation
WO1991012334A1 (en) * 1990-02-15 1991-08-22 Cetus Corporation Inhibitor of cytokine activity and applications thereof
US5216004A (en) * 1990-09-13 1993-06-01 Children's Hospital Medical Center Of North California Method for preventing malaria
EP0548276A4 (en) * 1990-09-13 1993-12-29 Children's Hospital Medical Center Of Northern California Method for increasing red blood cell production by treatment with activin or activin-related peptides
US5208219A (en) * 1991-02-14 1993-05-04 Celtrix Pharmaceuticals Inc. Method for inducing bone growth
EP0575555B1 (en) 1991-03-11 2001-07-18 Curis, Inc. Protein-induced morphogenesis
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
US5885794A (en) * 1991-05-10 1999-03-23 The Salk Institute For Biological Studies Recombinant production of vertebrate activin receptor polypeptides and identification of receptor DNAs in the activin/TGF-β superfamily
IL99867A0 (en) * 1991-10-27 1992-08-18 Yissum Res Dev Co Pharmaceutical compositions containing activin a
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
GB9206861D0 (en) * 1992-03-28 1992-05-13 Univ Manchester Wound healing and treatment of fibrotic disorders
US5428011A (en) * 1992-06-16 1995-06-27 Procyon Biopharma, Inc. Pharmaceutical preparations for inhibiting tumours associated with prostate adenocarcinoma
US5888720A (en) * 1992-10-27 1999-03-30 Yissum Research And Development Company Of The Hebrew University Of Jerusalem In vitro micro-organs
US5753612A (en) * 1992-10-27 1998-05-19 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
JPH07149659A (ja) * 1993-09-28 1995-06-13 Ajinomoto Co Inc 骨損傷治療剤
EP0754058B1 (en) * 1994-03-29 1999-11-03 The Victoria University Of Manchester Wound healing
WO1996015226A1 (en) 1994-11-14 1996-05-23 Neurospheres Holdings Ltd. Regulation of neural stem cell proliferation

Also Published As

Publication number Publication date
JPH11514373A (ja) 1999-12-07
JP4102437B2 (ja) 2008-06-18
US20040052795A1 (en) 2004-03-18
DE69633396D1 (de) 2004-10-21
DE69633396T2 (de) 2005-09-22
CA2235412C (en) 2010-01-19
US7713933B2 (en) 2010-05-11
ES2227610T3 (es) 2005-04-01
AU715255B2 (en) 2000-01-20
EP0855916B1 (en) 2004-09-15
ZA968785B (en) 1998-04-20
ATE275966T1 (de) 2004-10-15
DK0855916T3 (da) 2004-10-18
GB9521608D0 (en) 1996-01-03
GB2306481A (en) 1997-05-07
WO1997015321A1 (en) 1997-05-01
EP0855916A1 (en) 1998-08-05
CA2235412A1 (en) 1997-05-01
AU7313896A (en) 1997-05-15

Similar Documents

Publication Publication Date Title
AU6666096A (en) Pharmaceutical composition containing il-10
PT855916E (pt) Composicao farmaceutica contendo um estimulador de activina ou inibina
AU2001247968A1 (en) Use of asiatic acid or asiaticoside for treatment of cancer
AU1865100A (en) Hyaluronate lyase used for promoting penetration in topical agents
AU2838101A (en) Use of melatonin for treating androgenetic and diffuse alopecia
WO1998026770A3 (en) The topical use of kappa opioid agonists to treat ocular pain
CA2163118A1 (en) Aurintricaboxylic Acid Fractions and Analogues with Anti-Angiogenic Activity and Methods of Use
IL121272A (en) Pharmaceutical compositions comprising adenosine and their use for treating or preventing leukopenia
DE69813200D1 (de) Verbesserung der wundheilung mit cm101/gbs-toxin
GR3020355T3 (en) Aminosulfonyl urea acat inhibitors
CA2229010A1 (en) Mannose-6-phosphate analogues for the treatment of wounds and fibrotic disorders with reduced scarring
AU3919001A (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
AU1278600A (en) Novel therapeutic application of nicergoline
ZA966577B (en) Pharmaceutical composition.
AU2001276323A1 (en) Use of n-oleoylethanolamine for treating psoriasis
GB9723824D0 (en) Cytostatic agents
UA15363A (uk) Засіб для лікуваhhя відкритих пошкоджеhь
AU4123297A (en) Alkaloid glycoside for use as a medicament
UA8280A (uk) Спосіб лікування псоріазу
UA34333A (uk) Спосіб лікування тяжких форм флюорозу зубів
UA32314A (uk) Спосіб лікування некротичного панкреатиту
WO2000067733A3 (de) Medikament zur therapie der männlichen infertilität